Your innovative solutions can help bring answers to unmet needs in the following four areas:
neurotechprize: Accelerate your impact on Alzheimer’s disease
Through the neurotechprize, EIT Health and Biogen aim to rapidly accelerate maturity and/or market access of the most promising solutions and technologies addressing the challenge of Alzheimer’s disease in Germany.
As populations continue to age rapidly, Alzheimer’s disease (AD) has become one of the most pressing concerns for healthcare in the 21st century and a real societal burden.
We are searching for simple tech to deep tech solutions that can help improve the quality of life for those impacted by Alzheimer’s disease.
The most innovative projects can earn prizes of €100k for the winning solution and €50k for the runner-up. Selected teams will also gain access to the 3-month acceleration programme.
Please take note that applications for the neurotechprize are now closed.
Why get involved?
TAILORED JOURNEY
Tailored and customised three-month journey focused on your team’s objectives
DEEP EXPERTISE
Intensive mentoring from top experts in business and science plus access to industry stakeholders
FUNDING
€10k funding to support participation of founders and/or key team members in the journey
PRIZE MONEY
Pitch your solution to our jury to earn prizes of €100k (winning solution) and €50k (runner-up)
UNIQUE NETWORK
Raise the visibility of your start-up across the unique and vibrant EIT Health ecosystem of more than 140 partners
POSITIVE IMPACT
Change and improve the lives of hundreds of thousands of people affected by Alzheimer’s disease
Areas of intervention
Accelerating the diagnostic pathway
Help provide tools that shorten the time-consuming diagnostic pathway.
Improving disease monitoring
Put forward a solution to measure and analyze meaningful data that reflects the patients’ individual disease progression.
Easing burden on patients
Bring a patient-centered solution easing the burden for patients during the complex diagnosis and therapy pathway.
Maintaining quality of life
For Alzheimer’s patients and their families, it is crucial to maintain their quality of life while living with the disease. Also, behavioral disturbances related to Alzheimer’s (apathy, depression, anxiety, insomnia, etc.) pose an enormous challenge.
Who should apply
We call for applications from all around the globe, operating already or seeking to enter the German market and targeting the challenge of Alzheimer’s disease – see areas of intervention.
The programme is aimed at health entrepreneurs in the NeuroTech space seeking support in the validation of their ideas and developing business goals in a supportive and enriching environment.
Teams of minimum two people, incorporated start-ups, and non-incorporated teams are eligible to submit their entry to the programme.
Guidelines
See neurotechprize’s call document to learn more about the programme and its application process.
Apply now
Applications for the neurotechprize are now closed. Please take a look to our other EIT Health programmes that may be a good fit for your start-up
The neurotechprize Team
Collaborator
